Abstract
In addition to its well-known role as an adipostat in adult mammals, leptin has diverse physiological and developmental actions in vertebrates. Leptin has been shown to promote development of hypothalamic circuits and to induce mitosis in different brain areas of mammals. We investigated the ontogeny of leptin mRNA, leptin actions on cell proliferation in the brain, and gene expression in the preoptic area/hypothalamus of tadpoles of Xenopus laevis. The level of leptin mRNA was low in premetamorphic tadpoles, but increased strongly at the beginning of metamorphosis and peaked at metamorphic climax. This increase in leptin mRNA at the onset of metamorphosis correlated with increased cell proliferation in the neurogenic zones of tadpole brain. We found that intracerebroventricular (i.c.v.) injection of recombinant Xenopus leptin (rxLeptin) in premetamorphic tadpoles strongly increased cell proliferation in neurogenic zones throughout the tadpole brain. We conducted gene expression profiling of genes induced at 2 h following i.c.v. injection of rxLeptin. This analysis identified 2,322 genes induced and 1,493 genes repressed by rxLeptin. The most enriched Kyoto Encyclopedia of Genes and Genomes term was the canonical Wnt/β-catenin pathway. Using electroporation-mediated gene transfer into tadpole brain of a reporter vector responsive to the canonical Wnt/β-catenin signaling pathway, we found that i.c.v. rxLeptin injection activated Wnt/β-catenin-dependent transcriptional activity. Our findings show that leptin acts on the premetamorphic tadpole brain to induce cell proliferation, possibly acting via the Wnt/β-catenin signaling pathway.
Introduction
Leptin is a protein hormone secreted by adipocytes that signals energy stores to the adult brain. The plasma concentration of leptin fluctuates in proportion to fat mass, and leptin acts on feeding control centers in the hypothalamus to suppress food intake and increase whole body metabolism (1). Leptin (lep) and its receptor (LepR) are widely expressed, and the hormone has been shown to have pleiotropic actions in physiology and development of diverse vertebrate species (2, 3). The actions of leptin are mediated by the long form of the LepR (LepRb), which engages several intracellular signaling pathways, especially the Janus kinase 2/signal transducer and activator of transcription (JAK2/STAT) (4, 5) and phosphoinositide 3-kinase (PI3K) signaling pathways (6, 7).
Recent findings support that leptin has important roles in neurological development, especially development of leptin-responsive feeding control circuits in the hypothalamus. Leptin-deficient mice (ob/ob) have reduced brain weight, volume, and DNA content that can be restored by injecting leptin (4, 8). Leptin induces mitosis in several brain areas in rodents (8–10), and in tissue culture (11, 12), and this role for leptin is likely related to the brain size defects seen in ob/ob mice. The hormone also promotes formation of neuronal projections among hypothalamic nuclei involved with feeding (13–16).
In rodents, serum leptin concentration increases markedly in the neonate, then declines in the juvenile adult (17–19). This “postnatal leptin surge” may play a critical role in the development of the hypothalamic feeding control circuit (13, 15, 16). Cells in the ventricular zone (VZ)/subventricular zone (SVZ) of the third ventricle (3V) of neonates express functional LepR; LepR mRNA expression declines in the VZ/SVZ through development then appears in the arcuate nucleus and ventromedial hypothalamus (18). The LepR is expressed within the VZ of the 3V in embryonic/fetal brain (18, 20) and these neural progenitor/stem cells (NSCs) may be precursors of hypothalamic feeding control and hypophysiotropic neurons of the adult (21).
Genes for lep have now been isolated from numerous mammalian species, birds, reptiles, amphibians, and fishes (2, 3, 22). Our earlier findings in Xenopus support that the adipostat function of leptin was present in the earliest tetrapods (23, 24). By contrast, a role for leptin in feeding and energy balance in fishes remains unresolved (2, 3). Like mammals, tadpoles of Xenopus laevis develop competence to respond to leptin signaling during the postembryonic developmental period of metamorphosis (Melissa Cui Bender and Robert J. Denver, unpublished data). We found that functional LepR is expressed in regions surrounding the 3V of premetamorphic tadpole brain, suggesting that leptin can act within tadpole neurogenic zones. In the current study, we investigated whether leptin can promote mitosis in developing Xenopus tadpole brain by administering recombinant Xenopus leptin (rxLeptin) to premetamorphic tadpoles by intracerebroventricular (i.c.v.) injection, then we analyzed cells in M phase of the cell cycle using immunohistochemistry (IHC) for phosphorylated histone 3 (pH3). We also conducted a gene expression screen for early (2 h after i.c.v. rxLeptin injection) leptin-induced transcriptional changes in tadpole preoptic area/hypothalamus. This screen identified the canonical Wnt/β-catenin signaling pathway as the major intracellular signaling pathway induced by leptin in premetamorphic tadpole brain. Using electroporation-mediated (EM) gene transfer of a Wnt/β-catenin-responsive reporter plasmid into tadpole brain, we provide additional evidence that leptin activates functional Wnt/β-catenin signaling.
Materials and Methods
Animal Care and Use
We obtained X. laevis tadpoles from in-house breeding and raised them in dechlorinated tap water maintained at 21–23°C with a 12L:12D photoperiod. Tadpoles were fed frog brittle twice daily (NASCO, Fort Atkinson, WI, USA) and developmental stages were determined using the Nieuwkoop–Faber (NF) staging table (25). We anesthetized NF stage 50 X. laevis tadpoles (premetamorphic tadpoles) in a buffered solution of 0.002% benzocaine (Sigma) before administering i.c.v. injection of rxLeptin [produced as described by Crespi and Denver (23)], or plasmid injections for EM gene transfer (described below). For i.c.v. injection, we used a Drummond microinjector to deliver 50–150 nL of solution containing 0.6% saline, rxLeptin (20 ng/g BW) or plasmid DNA, plus 0.01% fast green dye to the area of the 3V as described previously (23, 24, 26). We chose this dose of rxLeptin based on our previously published work that showed that i.c.v. injection caused a dose-dependent suppression of food intake in the Western spadefoot toad, with 20 ng/g BW rxLeptin causing maximal suppression (23). Animals were killed by immersion in 0.1% benzocaine for 2 min before tissue harvest. All procedures involving animals were conducted under an approved animal use protocol (PRO00006809) in accordance with the guidelines of the Institutional Animal Care and Use Committee at the University of Michigan.
RNA Isolation for Gene Expression Analyses
For developmental analysis of lep mRNA, we extracted total RNA from whole animals beginning at NF stage 45. For NF stages 45–54, we pooled three animals per replicate and for NF stages 58–66, one animal per replicate (n = 5–6/NF stage). We also dissected and isolated total RNA from the portion of the carcass containing the fat pads (we removed tail and other organs; we refer to this as “adipose tissue”), liver, brain, and gut from tadpoles throughout metamorphosis (NF stages 50, 54, 58, 62, 66) for analysis of lep mRNA (n = 6/NF stage). For analysis of gene expression by microarray and reverse transcriptase quantitative real-time PCR (RTqPCR), we injected tadpoles i.c.v. with 0.6% saline or rxLeptin (20 ng/g BW), and 2 h later, we killed the animals, removed the brain, and microdissected the middle region of the brain (n = 6/treatment; the region of the diencephalon containing the preoptic area and hypothalamus, the neuroendocrine and feeding control regions of the brain) (27). We isolated RNA using the Trizol reagent (Invitrogen) following the manufacturer’s instructions.
For RTqPCR analysis of gene expression, we developed SYBR Green assays that spanned exon–exon boundaries for each gene. We treated 1 µg total RNA with 1.5 U RNase-free DNase I (Roche, Indianapolis, IN, USA) to digest contaminating genomic DNA, then reverse-transcribed the RNA into cDNA using 250 ng random hexamers and Superscript II Reverse Transcriptase (Invitrogen) following the manufacturer’s instructions [see also Ref. (28, 29)]. Minus RT controls were included. Oligonucleotides used for RTqPCR are given in Table 1. We conducted quantitative, real-time PCR using the ABsolute™ Blue qPCR SYBR Green Low Rox Mix (ABgene), and reactions were run on an ABI 7500 Fast qPCR machine. Relative quantities were determined using standard curves generated with pooled cDNAs.
Table 1
| Gene name | Forward | Reverse |
|---|---|---|
| ctnnb1 | 5′ GAATTGGCCACTCGAGCAA 3′ | 5′ ACCTGGTCCTCGTCATTAAGC 3′ |
| sox8 | 5′ GGGCAAACTGTGGCGTTTA 3′ | 5′ CTCAGCCTCCTCCACAAAGG 3′ |
| socs3 | 5′ AGAACCTACGCATCCAGTGTGA 3′ | 5′ GGCACTTCGTGGGTCAGTCT 3′ |
| arrb2 | 5′ TCAGTCAGACAATACGCAGACATC 3′ | 5′ GCCACCGGGCCACTTGTAC 3′ |
| dab2 | 5′ CAGCAGCTGCCACTGGAA 3′ | 5′ ATTGTTGTGCGTGAGAGTTTAC 3′ |
| mad2l1 | 5′ AAGAACTTGCAACCGTTAAACT 3′ | 5′ TCACGAACAATGCCGTCTTTC 3′ |
| rpL8 | 5′ TTTGCTGAAAGAAATGGCTACATC 3′ | 5′ CACGGCCTGGATCATGGA 3′ |
Sequences of oligonucleotide used to validate microarray results by SYBR Green reverse transcriptase quantitative real-time PCR.
IHC for pH3 and Phosphorylated STAT3 (pSTAT3)
We analyzed the effects of i.c.v. injection of rxLeptin on mitosis in the premetamorphic tadpole brain using IHC for pH3. The serine 10 at the amino terminus of H3 is phosphorylated during late G2 through M phase of the cell cycle and is therefore used to detect dividing cells [for X. laevis brain: (30–32)]. We administered two i.c.v. injections of 0.6% saline or rxLeptin (200 ng/g BW) (23) into the region of the 3V of NF stage 50 tadpoles; the second injection was 24 h after the first, and tadpoles were killed 48 h after the first injection (i.e., 24 h after the second injection). We then processed brains for IHC for pH3 following the method of Denver et al. (30). Briefly, we prepared 10 µm thick transverse cryosections through entire tadpole brains and immunostained sections with a rabbit antiserum against human pH3 (1:500; Cat. #0650 EMD Millipore, Billerica, MA, USA). Primary immune complexes were detected using a secondary antibody conjugated with Cy3 (1:500, Jackson ImmunoResearch Laboratories, Inc., West Grove, PA, USA). For IHC for pSTAT3, a marker for activated LepR, we administered i.c.v. injections of 0.6% saline or rxLeptin (20 ng/g BW) (24) to NF stage 50 tadpoles and collected brains 1 h later for fixation and sectioning. We conducted IHC for pSTAT3 on Xenopus brain as described previously (24) using an antiserum generated against a phosphopeptide AP[pY]LK from mouse STAT3 (Tyr705; 1:200; Cat. # 9131, Cell Signaling), which is 100% conserved with X. laevis STAT3 (24, 33). Images of immunostained slides were captured using an Olympus XI-81 microscope, and the total number of pH3 positive cells per brain was counted. Five brains were analyzed per treatment. Xenopus neuroanatomy is based on Tuinhof et al. (34) with modifications by Yao et al. (35).
DNA Microarray Analysis of Gene Expression after i.c.v. rxLeptin Injection
We conducted DNA microarray analysis on total RNA isolated from the preoptic area/hypothalamus of NF stage 54 X. laevis tadpoles (~0.2 g BW) 2 h after i.c.v. injection of 0.6% saline or rxLeptin (20 ng/g BW). We isolated total RNA from microdissected brain regions of three replicate pools (three brains per pool) per treatment. Samples were hybridized to the Affymetrix GeneChip Xenopus laevis Genome 2.0 Array (n = 3/treatment) at the Affymetrix and Microarray Core Facility at the University of Michigan. We selected a subset of the induced genes to cover a range of expression values (fold change) for validation by RTqPCR (Table 1).
Microarray Data Background Correction, Normalization, and Expression Quantification
We used the Robust Multichip Average method (36) from the Affy package (v1.52.0) (37) to calculate background-corrected, normalized expression values. Genefilter (v1.56.0) (38) was used to remove uninformative probesets (internal control probesets, or probesets with low variance or background level expression values).
Microarray Data Differential Expression Analysis and Annotation
Principal component analysis plots of the normalized, filtered samples showed samples of the same treatment (saline or rxLeptin) clustered together, and that the two treatments clustered separately. We used the limma package (v3.30.2) (39) to apply empirically derived array weights to individual samples, which were then used to calculate differential expression values (40). Annotations for each gene were added using the annotation file supplied by Affymetrix for the X. laevis Genome 2.0 Array.
Gene Ontology (GO) and Pathway Analysis
Gene ontology term enrichment analysis was conducted using a log2 fold change (log2FC) ranked list from limma, containing genes with a Benjamini and Hochberg (BH)-corrected p-value, or false-discovery rate (FDR) <0.05, as input into clusterProfiler (v3.2.4) (41). This analysis determines which molecular function, biological process, or cellular component GO terms are positively or negatively enriched in rxLeptin-treated samples compared with saline-treated controls, at a p-value < 0.05, while taking into account the magnitude and direction of change. Due to the hierarchical and redundant nature of GO terms, we obtained a summarized list of GO terms using Revigo to remove redundant terms (42).
We conducted Kyoto Encyclopedia of Genes and Genomes (KEGG) (43) pathways enrichment analysis using a log2FC ranked list of all differential gene expression data from limma (FDR < 0.05) as input into clusterProfiler (v3.2.4) (41). An additional KEGG module (highly annotated functional units of a metabolic network) enrichment analysis was conducted using the same log2FC ranked list as input into clusterProfiler (v3.2.4). Gene expression values for KEGG pathways were plotted on the respective pathways using the pathview package (v1.14.0) (44).
Enriched biological processes GO terms, KEGG pathways, and KEGG modules were displayed using the Enrichment Map application (v2.2.0) (45) in Cytoscape (v3.4.0) (46).
EM Gene Transfer and In Vivo Reporter Assay
We used EM gene transfer (30, 47–50) and i.c.v. microinjection of 0.6% saline or rxLeptin (20 ng/g BW) to investigate whether leptin can activate the Wnt/β-catenin signaling pathway in tadpole brain in vivo. We divided NF stage 50 tadpoles into three groups for bipolar electroporation. Tadpoles were electroporated with a DNA mixture containing pRenilla-null (50 ng/µL; for dual-luciferase assay normalization), pCMV-eGFP (500 ng/µL; to visualize transfection efficiency), and one of the following firefly luciferase reporter vectors (each at 1 μg/μL): pGL4.23 empty (negative control), GAS-luciferase (positive control for leptin activity) (23, 24) or pGL4.23-6TCF (reporter of activated canonical Wnt/β-catenin signaling). The pGL4.23-6TCF vector contains six T cell factor (TCF) sites upstream of a minimal promoter driving luciferase expression, and therefore reports activation of the canonical Wnt/β-catenin signaling pathway (gift of Dr. Ken Cadigan). A separate group of tadpoles received pGL4.23-6TCF, pRenilla-null, and pCMV-EGFP plus a constitutively active β-catenin expression vector pcDNA3-S33Y β-catenin (51) (gift of Dr. Eric Fearon) or an empty vector (pCMVneo-empty). Plasmid concentrations for electroporation are based on Yao et al. (52). Twenty-four hours after EM gene transfer we screened tadpoles for strong GFP expression, and then separated them into eight groups: pGL4.23-empty reporter, saline, or rxLeptin; GAS-luciferase, saline, or rxLeptin; pGL4.23-6TCF, saline, or rxLeptin; pGL4.23-6TCF, pCMVneo-empty, or pcDNA3-S33Y β-catenin. Tadpoles receiving i.c.v. injections were given saline or rxLeptin (20 ng/g BW). Two hours after injection, tadpoles were killed and brains harvested for dual-luciferase assay following the protocol described by Yao et al. (52). We had a sample size of eight tadpoles per treatment.
Data and Statistical Analysis
We analyzed data for gene expression by RTqPCR, pH3 cell counts and dual-luciferase assay data by one-way ANOVA or by unpaired Student’s t-test (p < 0.05). Derived values were log10-transformed before statistical analysis. Fisher’s least squares difference post hoc test was used to separate the means following ANOVA. We used the SYSTAT 13.0 computer program (SPSS Inc.).
Results
Ontogeny of lep mRNA in Tadpoles during Metamorphosis, and Effects of rxLeptin on Mitosis in Premetamorphic Tadpole Brain
Whole body lep mRNA increased 3.3-fold between stages 48 and 50, which is immediately before the onset of metamorphosis (p < 0.001, ANOVA; Figure 1A). The mRNA level increased further (7.6-fold) from stages 50 to 54, and remained elevated throughout metamorphosis and in the postmetamorphic frog (NF stage 66). The pattern of changes in lep mRNA in adipose tissue during metamorphosis was similar to whole body (Figure 1B; p = 0.002, ANOVA). By contrast, lep mRNA decreased in liver (p = 0.001) and was low and unchanged in brain throughout metamorphosis (Figure 1B). These findings, and other results from our laboratory support that fat tissue is the major source of lep mRNA in the tadpole (Melissa Cui Bender and Robert J. Denver, unpublished data). This developmental pattern of lep mRNA paralleled changes in cell proliferation in tadpole brain during metamorphosis (Figure 2A) (30). Injection of rxLeptin strongly increased pH3-immunoreactivity (35-fold; p < 0.0001; Student’s unpaired t-test) in cells within the VZ/SVZ throughout the tadpole brain (Figures 2B,C). Also, i.c.v. rxLeptin injection (1 h) induced the appearance of pSTAT3 immunoreactivity (pSTAT3-ir) in the VZ/SVZ in the region of the 3V (Figure 2D), supporting the expression of functional LepR in these cells. The inset in Figure 2D shows a high magnification view of the VZ/SVZ with elongated cells undergoing migration out of the neurogenic zone.
Figure 1
Figure 2
i.c.v. rxLeptin Injection Induces Rapid Transcriptional Responses in Early Premetamorphic (NF Stage 54) Tadpole Brain
To investigate the molecular basis for leptin action on tadpole brain, we conducted microarray analysis on the region of the diencephalon containing the preoptic area/hypothalamus of NF stage 54 tadpoles at 2 h following i.c.v. injection of 0.6% saline or rxLeptin injection (20 ng/g BW). The transformed log ratio (M) and mean average (A) plot (MA plot) in Figure 3A shows that the data are normally distributed, with a zero-centered transformed log ratio. Additionally, this plot shows that genes with a significant BH-adjusted p-value (FDR < 0.05), plotted in red, are distributed evenly across MA expression levels, indicating an ability to detect differentially expressed genes at any range of expression. This plot also indicates that an absolute log2 fold change (log2FC) as low as ~0.5 can be detected with confidence (FDR < 0.05). This analysis identified 2,322 induced and 1,493 repressed genes (Table S1 in Supplementary Material). The top 20 induced and repressed genes are given in Tables 2 and 3, respectively. The microarray dataset has been deposited in the Gene Expression Omnibus archive at the National Center for Biotechnology Information (GEO accession #GSE97243).
Figure 3
Table 2
| Gene symbol | Gene title | Entrez gene ID | log2 fold change | Adjusted p-value |
|---|---|---|---|---|
| LOC100036815/cxcl8 | Hypothetical protein LOC100036815/interleukin-8 | 100036815 | 2.63 | 0.00001 |
| ctnnb1 | Beta-catenin protein | 399274 | 2.32 | 0.00013 |
| ube2d3 | Ubiquitin-conjugating enzyme E2D 3 (UBC4/5 homolog) | 403384 | 2.23 | 0.00018 |
| lpar4 | Lysophosphatidic acid receptor 4 | 779407 | 2.07 | 0.00018 |
| aplp2 | Amyloid beta (A4) precursor-like protein 2 | 431790 | 2.03 | 0.00018 |
| set/TAF-Ibeta1 | SET nuclear oncogene///TAF-Ibeta1 | 379599///399349 | 1.94 | 0.00014 |
| brd2 | RING3 protein | 779057 | 1.94 | 0.00028 |
| mbd3 | Methyl-CpG binding domain protein 3 | 398135 | 1.87 | 0.00018 |
| dhcr7 | 7-Dehydrocholesterol reductase | 379273 | 1.87 | 0.00028 |
| gca | Grancalcin, EF-hand calcium binding protein | 444080 | 1.84 | 0.00014 |
| idh3a | Isocitrate dehydrogenase 3 (NAD+) alpha | 444419 | 1.75 | 0.00017 |
| gna11 | Guanine nucleotide binding protein (G protein), alpha 11 (Gq class) | 380535///779103 | 1.74 | 0.00026 |
| pin1 | Peptidylprolyl cis/trans isomerase, NIMA-interacting 1 | 503670 | 1.72 | 0.00018 |
| mad2l1 | MAD2 mitotic arrest deficient-like 1 | 380433 | 1.72 | 0.00074 |
| phyhipl | Phytanoyl-CoA 2-hydroxylase interacting protein-like | 447238 | 1.70 | 0.00037 |
| psat1 | Phosphoserine aminotransferase 1 | 494700 | 1.67 | 0.00013 |
| nrn1-A | Neuritin 1-A | 373709 | 1.66 | 0.00025 |
| ifrd1/MGC69123 | Interferon-related developmental regulator 1 | 379667///494857 | 1.63 | 0.00019 |
| tifa | TRAF-interacting protein with forkhead-associated domain | 734184 | 1.62 | 0.00026 |
| irf1 | Interferon regulatory factor 1 | 398826 | 1.60 | 0.00007 |
Top twenty genes with annotation induced by recombinant Xenopus leptin in premetamorphic tadpole brain.
Table 3
| Gene symbol | Gene title | Entrez gene ID | log2 fold change | Adjusted p-value |
|---|---|---|---|---|
| gtf2h2/MGC81060 | General transcription factor IIH subunit 2 | 443754 | −1.55 | 0.00027 |
| sfrs3 | Splicing factor, arginine serine-rich 3 | 380152 | −1.51 | 0.00018 |
| muc19 | Mucin 19, oligomeric | 378670 | −1.50 | 0.00018 |
| tmem14a | Transmembrane protein 14A | 444418 | −1.30 | 0.00613 |
| xcirp2 | Cold-inducible RNA binding protein 2 | 379484 | −1.22 | 0.00391 |
| prss3 | Protease, serine, 3 | 447093 | −1.16 | 0.01023 |
| tef | Thyrotrophic embryonic factor | 379940 | −1.14 | 0.00018 |
| hsp90aa1.1/MGC82579 | Heat shock protein 90 kDa alpha family class A member 1 | 444024 | −1.12 | 0.00030 |
| myh4 | Similar to myosin, heavy polypeptide 4, skeletal muscle | 399414 | −1.09 | 0.00145 |
| LOC100037078 | Hypothetical protein LOC100037078 | 100037078 | −1.09 | 0.01290 |
| pcca | Propionyl Coenzyme A carboxylase, alpha polypeptide | 734347 | −1.04 | 0.00330 |
| dnajc8 | DnaJ (Hsp40) homolog, subfamily C, member 8 | 447089 | −1.03 | 0.00224 |
| dhx.8S/MGC80994 | DEAH-box helicase 8 S homolog | 444315 | −1.03 | 0.00145 |
| LOC397871 | Larval beta II globin | 397871 | −1.02 | 0.00106 |
| MGC85304 | MGC85304 protein | 447105 | −1.02 | 0.00207 |
| MGC99235 | MGC99235 protein | 447690 | −1.01 | 0.00053 |
| MGC64236 | Hypothetical protein MGC64236 | 379516 | −1.01 | 0.00292 |
| scc2-1 | Scc2-1B | 445865 | −0.95 | 0.01224 |
| zmynd8 | Zinc finger, MYND-type containing 8 | 733267 | −0.94 | 0.01584 |
| hmgn1/MGC64236 | High mobility group nucleosome binding domain 1 | 379516 | −0.94 | 0.00244 |
Top twenty genes with annotation repressed by recombinant Xenopus leptin in premetamorphic tadpole brain.
Using these differential expression data, we conducted several enrichment analyses, allowing us to classify the global gene regulation changes into several general categories (general biological process regulation, metabolism, cellular components, adhesion, immune signaling, cell signaling, development, cell division and neurogenesis, and others) and highlighting several biological processes or pathways of interest. The enrichment map in Figure 3B shows these data: enriched biological process GO terms (p-value < 0.15), KEGG pathways (p-value < 0.15), and KEGG modules. We validated a subset of the induced genes by RTqPCR (Figure 4).
Figure 4
The top ten GO terms involved developmental processes (Figure 3B; Table 4; Table S2 in Supplementary Material). Noteworthy is the Wnt/β-catenin signaling pathway, which was found by each enrichment analysis (biological process GO, KEGG pathway, KEGG module; Figure 5). Also, signaling by two TGFβ family members, bone morphogenetic protein (BMP) and activin, was among the enriched KEGG modules (Figure 6; Table S3 in Supplementary Material; tab KEGGmodules.filt). The hedgehog and insulin signaling pathways were also found to be enriched (Figures S1 and S2 in Supplementary Material).
Table 4
| ID | Description | Set size | Enrichment score | NES | p-Value | p.adjust | q-Values |
|---|---|---|---|---|---|---|---|
| GO:0044767 | Single-organism developmental process | 470 | 0.298665447 | 1.479435427 | 0.00101833 | 0.159221311 | 0.159221311 |
| GO:0048856 | Anatomical structure development | 452 | 0.305758564 | 1.512476805 | 0.00101833 | 0.159221311 | 0.159221311 |
| GO:0032502 | Developmental process | 473 | 0.305340626 | 1.513106572 | 0.001019368 | 0.159221311 | 0.159221311 |
| GO:0044707 | Single-multicellular organism process | 433 | 0.301770432 | 1.490562662 | 0.001023541 | 0.159221311 | 0.159221311 |
| GO:0032501 | Multicellular organismal process | 463 | 0.29984464 | 1.483930907 | 0.00102459 | 0.159221311 | 0.159221311 |
| GO:0007275 | Multicellular organism development | 407 | 0.300744558 | 1.475210668 | 0.003089598 | 0.400102987 | 0.400102987 |
| GO:0030154 | Cell differentiation | 203 | 0.319354548 | 1.47945519 | 0.004429679 | 0.491694352 | 0.491694352 |
| GO:0009790 | Embryo development | 84 | 0.391329957 | 1.634661027 | 0.006157635 | 0.598060345 | 0.598060345 |
| GO:0048513 | Animal organ development | 137 | 0.342563144 | 1.530163684 | 0.007900677 | 0.649743161 | 0.649743161 |
| GO:0048869 | Cellular developmental process | 242 | 0.301733778 | 1.42896268 | 0.008583691 | 0.649743161 | 0.649743161 |
Top ten gene ontology (GO) terms corresponding to developmental processes.
Figure 5
Figure 6
Wnt/β-Catenin Signaling Is Activated in Premetamorphic Tadpole Brain by i.c.v. rxLeptin Injection
To test if leptin can activate the canonical Wnt/β-catenin signaling pathway in tadpole brain in vivo, we conducted EM gene transfer with different reporter plasmids, and injected saline or rxLeptin i.c.v. Injection of rxLeptin did not alter luciferase activity in pGL4.23-empty vector-transfected brain, but caused a strong increase (12.9-fold; p < 0.0001, unpaired Student’s t-test) in luciferase driven by the GAS-luciferase vector, which reports pSTAT3 signaling induced by leptin binding to the LepR (Figure 7) (23, 24). This confirmed activation of LepR signaling in tadpole brain after i.c.v. rxLeptin injection. We observed a threefold increase in luciferase activity (p < 0.001) driven by the pGL4.23-6TCF (Wnt/β-catenin pathway) reporter vector following injection of rxLeptin. Forced expression of constitutively active β-catenin confirmed the activity of the pGL4.23-6TCF reporter (47-fold increase; p < 0.0001).
Figure 7
Discussion
Leptin has well-established roles in adult physiology, but its developmental actions are less understood. Here, we show that lep expression increases strongly during tadpole metamorphosis in parallel with an increase in mitosis in tadpole brain. Also, i.c.v. injection of rxLeptin induced mitosis in neurogenic zones of premetamorphic tadpole brain. Gene expression screening identified genes regulated by leptin signaling in early premetamorphic tadpole brain, and highlighted several signaling pathways (Wnt/β-catenin, TGFβ, hedgehog, and insulin signaling) through which leptin may effect its regulatory role in neurogenesis. We also show that leptin activates Wnt/β-catenin pathway signaling in tadpole brain in vivo, as evidenced by activation of a Wnt/β-catenin pathway reporter vector.
Leptin Promotes Neurogenesis in Xenopus Tadpole Brain
We observed a strong induction of mitosis in neurogenic zones of the premetamorphic tadpole brain following i.c.v. injection of rxLeptin. The rapid increase in pSTAT3-ir in cells of these regions 1 h after rxLeptin injection supports that they express functional LepR, and therefore that the action of leptin on mitosis is likely to be direct. In rodent embryonic/fetal brain, LepR mRNA is expressed within the VZ/SVZ of the 3V (18, 20). The LepR mRNA level in the VZ/SVZ declines through development, after which time it appears in the arcuate nucleus and ventromedial hypothalamus (18). These LepR mRNA-expressing NSCs may be precursors of hypothalamic feeding control and hypophysiotropic neurons of the adult (21). The LepR is also expressed in the VZ/SVZ (progenitor cell niches) of adult monkey brain (53).
Several lines of evidence from studies in rodents support that leptin controls cell proliferation in developing brain and can also induce neurogenesis in adults. For example, the reduced brain weight and DNA content in ob/ob mice is restored by leptin injection (4, 8), and leptin has been found to induce mitosis in rodent brain in vivo (8–10), and in tissue culture (11, 12). The large increase in lep mRNA in tadpoles during metamorphosis, a postembryonic developmental period that has been compared to the neonatal/early postnatal period in direct developing species like mammals (54), may be similar, both phenomenologically and functionally, to the postnatal leptin surge that occurs in rodents (17–19). It has been hypothesized that this postnatal increase in leptin plays a pivotal role in the development of the hypothalamic feeding control circuitry (13, 15, 16, 55–56). Leptin has also been shown to promote neurogenesis in the hippocampus of adult mammals (57), which may depend on Wnt/β-catenin signaling (58). The extra-hypothalamic actions of leptin on adult neurogenesis and neural plasticity may improve cognition and mood in animal models of depression and anxiety, and circulating leptin concentration is negatively correlated with Alzheimer’s disease in humans (59), and promotes neurogenesis in a mouse model of Alzheimer’s disease (60). Leptin has also been shown to be neuroprotective and induces neurogenesis and angiogenesis after stroke (61–63).
Cell proliferation in tadpole brain during metamorphosis depends on thyroid hormone (30). However, other mitogens such as leptin, activators of the TGFβ pathway, neurotrophins, and insulin-like peptides likely also play important roles in this developmental process. Indeed, there may be synergy between different signaling pathways, some that are affected by nutritional state like leptin and insulin-like peptides, that determine cell expansion and development of neural structures and pathways. Leptin has been found to synergize with thyroid hormone to induce proliferation of chondrocytes in growth plates, and also to promote terminal differentiation (64). Whether similar synergy occurs in the developing brain, which is critically dependent on thyroid hormone for its development, requires further study.
Leptin Activates Canonical Wnt/β-Catenin Signaling in Xenopus Tadpole Brain
Using gene expression screening, we discovered sets of genes that are rapidly induced or repressed by leptin signaling in the tadpole preoptic area/hypothalamus. The major pathways regulated by leptin included the Wnt/β-catenin and TGFβ signaling pathways. Notably, we identified several genes involved in the Wnt/β-catenin signaling pathway, including β-catenin, the central component of the canonical Wnt/β-catenin pathway. The Wnt proteins, and the canonical Wnt/β-catenin intracellular signaling pathway, play central roles in development and disease (65), including development of the central nervous system, and are known to promote cell proliferation (66). The Wnt ligands bind to cell surface receptors of the Frizzled (Fz) and low-density lipoprotein-related protein families (67). In canonical Wnt/β-catenin signaling, the absence of Wnt ligand causes cytoplasmic signaling components such as glycogen synthase kinase 3β (GSK3β) to phosphorylate β-catenin, leading to the latter’s degradation. Activation of Wnt receptors leads to phosphorylation of GSK3β, allowing β-catenin to accumulate in the cytoplasm. The accumulated β-catenin translocates to the nucleus, where it interacts with lymphoid enhancer-binding factor 1 with lymphoid enhancer-binding factor 1 (also known as TCF) to activate transcription of Wnt/β-catenin target genes (67, 68).
In addition to the Wnt receptor Fzd10 and β-catenin (ctnnb1), one of the TCFs, Tcf7l1 (also known as TCF-3) was induced by leptin in tadpole brain. This transcription factor is a transcriptional repressor (67) and was recently found to promote growth of colorectal cancers (69). Myc was also identified in our screen and is a Wnt/β-catenin target gene that functions in mitosis (70). The cyclin-dependent kinase 10 was induced by leptin and is known to be modulated by Wnt/β-catenin signaling (66, 71).
There is mounting evidence from different systems and tissues that leptin induction of mitosis and cell survival depends on Wnt/β-catenin signaling (72, 73). For example, the level of β-catenin in the cytoplasm is maintained low through continuous proteasome-mediated degradation controlled by a protein complex of GSK3/APC/Axin (65). Phosphorylation of GSK3 on serine 9 by activated Wnt/β-catenin signaling leads to destruction of this complex and the accumulation of β-catenin. β-Catenin translocates to the nucleus to regulate gene transcription (65). Leptin acts as a growth factor for different kinds of tumor cells (73, 74), causes rapid nuclear translocation of β-catenin, and activates other components of the Wnt/β-catenin pathway (74–76). Leptin-dependent activation of Wnt/β-catenin signaling has also been shown to play a role in leptin action in the adult hypothalamus to modulate glucose homeostasis and energy balance (77–80).
Leptin Modulates TGFβ, Hedgehog, and Insulin Signaling in Xenopus Tadpole Brain
After the Wnt/β-catenin pathway, the next most enriched pathway activated by leptin in tadpole brain was that regulated by the TGFβ superfamily of ligands, in particular bone BMP and activin. The TGFβ signaling pathway plays central roles in animal development, including cell proliferation, cell differentiation, and apoptosis (81, 82). Several components of this pathway were modulated by leptin in tadpole brain, including ligands, cell surface receptors, and receptor-activated transcription factors of the SMAD family (see Figure 6).
The hedgehog signaling pathway was also found to be activated by leptin (Figure S1 in Supplementary Material). A proposed mechanism of leptin-induced neurogenesis in murine transient amplifying neuroblasts involves hedgehog signaling regulation (83). We also found that leptin modulated components of the insulin signaling pathway (see Figure S2 in Supplementary Material). Interactions between leptin and insulin signaling, and potential therapeutic uses for leptin in normalizing type 2 diabetes have been described recently (84–86). The signal transduction pathways initiated by insulin and leptin are both distinct and overlapping. For example, leptin activates the JAK2–STAT pathway, while insulin activates the mitogen-activated protein kinase pathway. Both insulin and leptin appear to activate the PI3K pathway. Recent findings show that insulin can potentiate leptin signaling (87).
Leptin and Developmental Programming
Early life nutrition (from maternal source—placenta or yolk, or from feeding—larva) can influence adipocyte production of leptin in the fetus (88, 89) or larva (Xenopus, Melissa Cui Bender and Robert J. Denver, unpublished data). Alterations in hormone production, influenced by nutrition during critical periods of development can affect the timing of development, and exert lasting effects on the structure and function of hypothalamic feeding and neuroendocrine circuits, a phenomenon termed developmental programming (88–93). There is mounting evidence that early life nutrition is an important determinant for risk of obesity (94), and modulation of leptin signaling during critical developmental periods can have long-term consequences for adult physiology (95–99). In animal models, undernutrition during pregnancy leads to a premature leptin surge, and offspring develop leptin resistance as adults, especially following a high-fat diet (100). A decrease or loss of leptin signaling in early postnatal life impairs development of the feeding circuit, and also predisposes individuals to leptin resistance and obesity as adults (95–99, 101–103).
The cellular and molecular mechanisms by which leptin acts on the developing brain to “program” the hypothalamic feeding control circuit are poorly understood (104). One possible mechanism of action is for circulating leptin in the neonate/tadpole to act within neurogenic zones of the developing brain to induce expansion of a LepR expressing cell population, which ultimately establishes the leptin-responsive network in the hypothalamus and other brain regions. Mammals develop competence to respond to leptin signaling during early postnatal development (15, 16, 105); amphibians develop competence to respond to leptin during early premetamorphosis (Melissa Cui Bender and Robert J. Denver, unpublished data). Functional LepR is detected in the VZ/SVZ during early postnatal development in rodents (18) and premetamorphosis in Xenopus (Figure 2D). Based on our findings and those in the literature, we hypothesize that leptin acts on the neural progenitor population via Wnt/β-catenin signaling to induce mitosis and promote cell survival.
Future fate mapping studies can investigate if cells born in the ependymal layer following leptin injection migrate to and populate the preoptic area and ventral hypothalamus. It will also be interesting to investigate the consequences of aberrant leptin signaling during early postembryonic development on later-life physiology and hypothalamic feeding control centers using the Xenopus model system. Leptin signaling in early stage Xenopus tadpole brain can be easily activated by i.c.v. injection of rxLeptin. Furthermore, cells in the tadpole VZ/SVZ can be transfected by EM gene transfer with expression plasmids (e.g., pCS2-xLepR) to force LepR expression in stem/progenitor cells, followed by injection of rxLeptin i.c.v. to activate LepR signaling. We predict that forced expression of LepR in progenitor/stem cells in the developing brain will promote proliferation followed by differentiation of these cells into the LepR expressing lineage.
Statements
Ethics statement
All procedures involving animals were conducted under an approved animal use protocol (PRO00006809) in accordance with the guidelines of the Institutional Animal Care and Use Committee at the University of Michigan.
Author contributions
MB participated in the design of experiments, conducted the leptin mRNA analysis, immunohistochemistry for pH3, DNA microarray analyses and electroporation-mediated gene transfer, and participated in writing the manuscript. CS did the bioinformatics analyses of the DNA microarray data and participated in writing the manuscript. RD participated in the design of experiments, analysis of the data, and in writing the manuscript.
Acknowledgments
This research was supported by a grant from the National Science Foundation (IOS 0641587) to RD. The authors thank Caroline Hu for technical assistance with pSTAT3 IHC, and Ken Cadigan and Eric Fearon for providing plasmids.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The handling editor declared a shared affiliation, though no other collaboration, with the authors, and the handling editor states that the process met the standards of a fair and objective review.
Supplementary material
The Supplementary Material for this article can be found online at http://journal.frontiersin.org/article/10.3389/fendo.2017.00099/full#supplementary-material.
References
1
MortonGJCummingsDEBaskinDGBarshGSSchwartzMW. Central nervous system control of food intake and body weight. Nature (2006) 443:289–95.10.1038/nature05026
2
DenverRJBonettRMBoorseGC. Evolution of leptin structure and function. Neuroendocrinology (2011) 94:21–38.10.1159/000328435
3
LondravilleRLMacotelaYDuffRJEasterlingMRLiuQCrespiEJ. Comparative endocrinology of leptin: assessing function in a phylogenetic context. Gen Comp Endocrinol (2014) 203:146–57.10.1016/j.ygcen.2014.02.002
4
AhimaRSOseiSY. Leptin signaling. Physiol Behav (2004) 81:223–41.10.1016/j.physbeh.2004.02.014
5
MyersMGCowleyMAMunzbergH. Mechanisms of leptin action and leptin resistance. Annu Rev Physiol (2008) 70:537–56.10.1146/annurev.physiol.70.113006.100707
6
WaumanJTavernierJ. Leptin receptor signaling: pathways to leptin resistance. Front Biosci (Landmark Ed) (2011) 16:2771–93.10.2741/3885
7
XuAWKaelinCBTakedaKAkiraSSchwartzMWBarshGS. PI3K integrates the action of insulin and leptin on hypothalamic neurons. J Clin Invest (2005) 115:951–8.10.1172/JCI200524301
8
SteppanCMSwickAG. A role for leptin in brain development. Biochem Biophys Res Commun (1999) 256:600–2.10.1006/bbrc.1999.0382
9
UdagawaJHashimotoRSuzukiHHattaTSotomaruYHiokiKet alThe role of leptin in the development of the cerebral cortex in mouse embryos. Endocrinology (2006) 147:647–58.10.1210/en.2005-0791
10
UdagawaJHattaTHashimotoROtaniH. Roles of leptin in prenatal and perinatal brain development. Congenit Anom (2007) 47:77–83.10.1111/j.1741-4520.2007.00150.x
11
DesaiMLiTRossMG. Fetal hypothalamic neuroprogenitor cell culture: preferential differentiation paths induced by leptin and insulin. Endocrinology (2011) 152:3192–201.10.1210/en.2010-1217
12
DesaiMLiTRossMG. Hypothalamic neurosphere progenitor cells in low birth-weight rat newborns: neurotrophic effects of leptin and insulin. Brain Res (2011) 1378:29–42.10.1016/j.brainres.2010.12.080
13
BouretSGDraperSJSimerlyRB. Formation of projection pathways from the arcuate nucleus of the hypothalamus to hypothalamic regions implicated in the neural control of feeding behavior in mice. J Neurosci (2004) 24:2797–805.10.1523/JNEUROSCI.5369-03.2004
14
BouretSGDraperSJSimerlyRB. Trophic action of leptin on hypothalamic neurons that regulate feeding. Science (2004) 304:108–10.10.1126/science.1095004
15
BouretSGSimerlyRB. Minireview: leptin and development of hypothalamic feeding circuits. Endocrinology (2004) 145:2621–6.10.1210/en.2004-0231
16
BouretSGSimerlyRB. Development of leptin-sensitive circuits. J Neuroendocrinol (2007) 19:575–82.10.1111/j.1365-2826.2007.01563.x
17
AhimaRSPrabakaranDFlierJS. Postnatal leptin surge and regulation of circadian rhythm of leptin by feeding – implications for energy homeostasis and neuroendocrine function. J Clin Invest (1998) 101:1020–7.10.1172/JCI1176
18
CottrellECCrippsRLDuncanJSBarrettPMercerJGHerwigAet alDevelopmental changes in hypothalamic leptin receptor: relationship with the postnatal leptin surge and energy balance neuropeptides in the postnatal rat. Am J Physiol Regul Integr Comp Physiol (2009) 296:R631–9.10.1152/ajpregu.90690.2008
19
CottrellECMercerJGOzanneSE. Postnatal development of hypothalamic leptin receptors. Vitam Horm (2010) 82:201–17.10.1016/S0083-6729(10)82011-4
20
UdagawaJHattaTNaoraHOtaniH. Expression of the long form of leptin receptor (Ob-Rb) mRNA in the brain of mouse embryos and newborn mice. Brain Res (2000) 868:251–8.10.1016/S0006-8993(00)02334-9
21
IshiiYBouretSG. Embryonic birthdate of hypothalamic leptin-activated neurons in mice. Endocrinology (2012) 153:3657–67.10.1210/en.2012-1328
22
ProkopJWSchmidtCGasperDDuffRJMilstedAOhkuboTet alDiscovery of the elusive leptin in birds: identification of several ‘missing links’ in the evolution of leptin and its receptor. PLoS One (2014) 9:e92751.10.1371/journal.pone.0092751
23
CrespiEJDenverRJ. Leptin (ob gene) of the South African clawed frog Xenopus laevis. Proc Natl Acad Sci U S A (2006) 103:10092–7.10.1073/pnas.0507519103
24
CuiMYHuCKPelletierCDziubaASlupskiRHLiCet alAncient origins and evolutionary conservation of intracellular and neural signaling pathways engaged by the leptin receptor. Endocrinology (2014) 155:4202–14.10.1210/en.2014-1301
25
NieuwkoopPDFaberJ. Normal Table of Xenopus laevis (Daudin). New York: Garland Publishing Inc. (1994).
26
CrespiEJDenverRJ. Roles of stress hormones in food intake regulation in anuran amphibians throughout the life cycle. Comp Biochem Physiol A Mol Integr Physiol (2005) 141:381–90.10.1016/j.cbpb.2004.12.007
27
HuFKnoedlerJRDenverRJ. A mechanism to enhance cellular responsivity to hormone action: Kruppel-like factor 9 promotes thyroid hormone receptor-beta autoinduction during postembryonic brain development. Endocrinology (2016) 157:1683–93.10.1210/en.2015-1980
28
BagamasbadPHowdeshellKLSachsLMDemeneixBADenverRJ. A role for basic transcription element-binding protein 1 (BTEB1) in the autoinduction of thyroid hormone receptor beta. J Biol Chem (2008) 283:2275–85.10.1074/jbc.M709306200
29
ManzonRGDenverRJ. Regulation of pituitary thyrotropin gene expression during Xenopus metamorphosis: negative feedback is functional throughout metamorphosis. J Endocrinol (2004) 182:273–85.10.1677/joe.0.1820273
30
DenverRJHuFScanlanTSFurlowJD. Thyroid hormone receptor subtype specificity for hormone-dependent neurogenesis in Xenopus laevis. Dev Biol (2009) 326:155–68.10.1016/j.ydbio.2008.11.005
31
SakaYSmithJC. Spatial and temporal patterns of cell division during early Xenopus embryogenesis. Dev Biol (2001) 229:307–18.10.1006/dbio.2000.0101
32
SchreiberAMDasBHuangHCMarsh-ArmstrongNBrownDD. Diverse developmental programs of Xenopus laevis metamorphosis are inhibited by a dominant negative thyroid hormone receptor. Proc Natl Acad Sci U S A (2001) 98:10739–44.10.1073/pnas.191361698
33
NishinakamuraRMatsumotoYMatsudaTAriizumiTHeikeTAsashimaMet alActivation of Stat3 by cytokine receptor gp130 ventralizes Xenopus embryos independent of BMP-4. Dev Biol (1999) 216:481–90.10.1006/dbio.1999.9518
34
TuinhofRGonzalezASmeetsWRoubosEW. Neuropeptide Y in the developing and adult brain of the South African clawed toad Xenopus laevis. J Chem Neuroanat (1994) 7:271–83.10.1016/0891-0618(94)90018-3
35
YaoMWestphalNDenverR. Distribution and acute stressor-induced activation of corticotrophin-releasing hormone neurones in the central nervous system of Xenopus laevis. J Neuroendocrinol (2004) 16:880–93.10.1111/j.1365-2826.2004.01246.x
36
IrizarryRAHobbsBCollinFBeazer-BarclayYDAntonellisKJScherfUet alExploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics (2003) 4:249–64.10.1093/biostatistics/4.2.249
37
GautierLCopeLBolstadBMIrizarryRA. affy – analysis of Affymetrix GeneChip data at the probe level. Bioinformatics (2004) 20:307–15.10.1093/bioinformatics/btg405
38
GentlemanRCareyVHuberWHahneF. genefilter: genefilter: methods for filtering genes from high-throughput experiments. R package version 1.50.0.
39
RitchieMEDiyagamaDNeilsonJvan LaarRDobrovicAHollowayAet alEmpirical array quality weights in the analysis of microarray data. BMC Bioinformatics (2006) 7:261.10.1186/1471-2105-7-261
40
SmythGK. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol (2004) 3:Article3.10.2202/1544-6115.1027
41
YuGCWangLGHanYYHeQY. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS (2012) 16:284–7.10.1089/omi.2011.0118
42
SupekFBosnjakMSkuncaNSmucT. REVIGO summarizes and visualizes long lists of gene ontology terms. PLoS One (2011) 6:e21800.10.1371/journal.pone.0021800
43
OgataHGotoSFujibuchiWKanehisaM. Computation with the KEGG pathway database. Biosystems (1998) 47:119–28.10.1016/S0303-2647(98)00017-3
44
LuoWJBrouwerC. Pathview: an R/Bioconductor package for pathway-based data integration and visualization. Bioinformatics (2013) 29:1830–1.10.1093/bioinformatics/btt285
45
MericoDIsserlinRStuekerOEmiliABaderGD. Enrichment map: a network-based method for gene-set enrichment visualization and interpretation. PLoS One (2010) 5:e13984.10.1371/journal.pone.0013984
46
ShannonPMarkielAOzierOBaligaNSWangJTRamageDet alCytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res (2003) 13:2498–504.10.1101/gr.1239303
47
BoorseGCKholdaniCASeasholtzAFDenverRJ. Corticotropin-releasing factor is cytoprotective in Xenopus tadpole tail: coordination of ligand, receptor, and binding protein in tail muscle cell survival. Endocrinology (2006) 147:1498–507.10.1210/en.2005-1273
48
HaasKJensenKSinWCFoaLClineHT. Targeted electroporation in Xenopus tadpoles in vivo – from single cells to the entire brain. Differentiation (2002) 70:148–54.10.1046/j.1432-0436.2002.700404.x
49
YaoMDenverRJ. Regulation of vertebrate corticotropin-releasing factor genes. Gen Comp Endocrinol (2007) 153:200–16.10.1016/j.ygcen.2007.01.046
50
YaoMSchulkinJDenverRJ. Evolutionarily conserved glucocorticoid regulation of corticotropin-releasing factor expression. Endocrinology (2008) 149:2352–60.10.1210/en.2007-1551
51
KolligsFTHuGDangCVFearonER. Neoplastic transformation of RK3E by mutant beta-catenin requires deregulation of Tcf/Lef transcription but not activation of c-myc expression. Mol Cell Biol (1999) 19:5696–706.10.1128/MCB.19.8.5696
52
YaoMStenzel-PooreMDenverRJ. Structural and functional conservation of vertebrate corticotropin-releasing factor genes: evidence for a critical role for a conserved cyclic AMP response element. Endocrinology (2007) 148:2518–31.10.1210/en.2006-1413
53
TonchevAB. Expression of leptin receptor in progenitor cell niches of adult monkey brain. C R Acad Bulg Sci (2008) 61:1219–24.
54
TataJR. Amphibian metamorphosis as a model for the developmental actions of thyroid hormone. Mol Cell Endocrinol (2006) 246:10–20.10.1016/j.mce.2005.11.024
55
BouretSG. Development of hypothalamic neural networks controlling appetite. In: LanghansWGearyN, editors. Frontiers in Eating and Weight Regulation. Basel: S. Karger AG (2010). p. 84–93.
56
BouretSG. Neurodevelopmental actions of leptin. Brain Res (2010) 1350:2–9.10.1016/j.brainres.2010.04.011
57
GarzaJCGuoMZhangWLuXY. Leptin increases adult hippocampal neurogenesis in vivo and in vitro. J Biol Chem (2008) 283:18238–47.10.1074/jbc.M800053200
58
GarzaJCGuoMZhangWLuXY. Leptin restores adult hippocampal neurogenesis in a chronic unpredictable stress model of depression and reverses glucocorticoid-induced inhibition of GSK-3 beta/beta-catenin signaling. Mol Psychiatry (2012) 17:790–808.10.1038/mp.2011.161
59
PazGWongMLLicinioJ. The procognitive effects of leptin in the brain and their clinical implications. Int J Clin Pract (2010) 64:1808–12.10.1111/j.1742-1241.2010.02536.x
60
Perez-GonzalezRAntequeraDVargasTSpuchCBolosMCarroE. Leptin induces proliferation of neuronal progenitors and neuroprotection in a mouse model of Alzheimer’s disease. J Alzheimers Dis (2011) 24:17–25.10.3233/JAD-2011-102070
61
AvrahamYDavidiNLassriVVorobievLKabesaMDayanMet alLeptin induces neuroprotection neurogenesis and angiogenesis after stroke. Curr Neurovasc Res (2011) 8:313–22.10.2174/156720211798120954
62
ParimisettyADorsemansACAwadaRRavananPDiotelNd’HellencourtCL. Secret talk between adipose tissue and central nervous system via secreted factors-an emerging frontier in the neurodegenerative research. J Neuroinflammation (2016) 13:67.10.1186/s12974-016-0530-x
63
TangBL. Leptin as a neuroprotective agent. Biochem Biophys Res Commun (2008) 368:181–5.10.1016/j.bbrc.2008.01.063
64
WangLShaoYYBallockRT. Leptin synergizes with thyroid hormone signaling in promoting growth plate chondrocyte proliferation and terminal differentiation in vitro. Bone (2011) 48:1022–7.10.1016/j.bone.2011.02.012
65
LoganCYNusseR. The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol (2004) 20:781–810.10.1146/annurev.cellbio.20.010403.113126
66
DavidsonG. The cell cycle and Wnt. Cell Cycle (2010) 9:1667–8.10.4161/cc.9.9.11595
67
CadiganKMWatermanML. TCF/LEFs and Wnt signaling in the nucleus. Cold Spring Harb Perspect Biol (2012) 4:a007906.10.1101/cshperspect.a007906
68
CleversH. Wnt/beta-catenin signaling in development and disease. Cell (2006) 127:469–80.10.1016/j.cell.2006.10.018
69
MurphyMChatterjeeSSJainSKatariMDasGuptaR. TCF7L1 modulates colorectal cancer growth by inhibiting expression of the tumor-suppressor gene EPHB3. Sci Rep (2016) 6:28299.10.1038/srep28299
70
StephensWZSenecalMNguyenMPiotrowskiT. Loss of adenomatous polyposis coli (apc) results in an expanded ciliary marginal zone in the zebrafish eye. Dev Dyn (2010) 239:2066–77.10.1002/dvdy.22325
71
DavidsonGNiehrsC. Emerging links between CDK cell cycle regulators and Wnt signaling. Trends Cell Biol (2010) 20:453–60.10.1016/j.tcb.2010.05.002
72
DohertyGHOldreiveCHarveyJ. Neuroprotective actions of leptin on central and peripheral neurons in vitro. Neuroscience (2008) 154:1297–307.10.1016/j.neuroscience.2008.04.052
73
EndoHHosonoKUchiyamaTSakaiESugiyamaMTakahashiHet alLeptin acts as a growth factor for colorectal tumours at stages subsequent to tumour initiation in murine colon carcinogenesis. Gut (2011) 60:1363–71.10.1136/gut.2010.235754
74
AritaSKinoshitaYUshidaKEnomotoAInagaki-OharaK. High-fat diet feeding promotes stemness and precancerous changes in murine gastric mucosa mediated by leptin receptor signaling pathway. Arch Biochem Biophys (2016) 610:16–24.10.1016/j.abb.2016.09.015
75
FentonJILavigneJAPerkinsSNLiuHChandramouliGVRShihJHet alMicroarray analysis reveals that leptin induces autocrine/paracrine cascades to promote survival and proliferation of colon epithelial cells in an Apc genotype-dependent fashion. Mol Carcinog (2008) 47:9–21.10.1002/mc.20357
76
YanDAvtanskiDSaxenaNKSharmaD. Leptin-induced epithelial-mesenchymal transition in breast cancer cells requires beta-catenin activation via Akt/GSK3- and MTA1/Wnt1 protein-dependent pathways. J Biol Chem (2012) 287:8598–612.10.1074/jbc.M111.322800
77
BenzlerJAndrewsZBPrachtCStohrSShepherdPRGrattanDRet alHypothalamic Wnt signalling is impaired during obesity and reinstated by leptin treatment in male mice. Endocrinology (2013) 154:4737–45.10.1210/en.2013-1746
78
BenzlerJGanjamGKKrugerMPinkenburgOKutschkeMStohrSet alHypothalamic glycogen synthase kinase 3 beta has a central role in the regulation of food intake and glucose metabolism. Biochem J (2012) 447:175–84.10.1042/BJ20120834
79
BoucseinABenzlerJHemppCStohrSHelferGTupsA. Photoperiodic and diurnal regulation of Wnt signaling in the arcuate nucleus of the female Djungarian hamster, Phodopus sungorus. Endocrinology (2016) 157:799–809.10.1210/en.2015-1708
80
HelferGTupsA. Hypothalamic Wnt signalling and its role in energy balance regulation. J Neuroendocrinol (2016) 28:12368.10.1111/jne.12368
81
MoustakasAHeldinCH. The regulation of TGF beta signal transduction. Development (2009) 136:3699–714.10.1242/dev.030338
82
RossSHillCS. How the Smads regulate transcription. Int J Biochem Cell Biol (2008) 40:383–408.10.1016/j.biocel.2007.09.006
83
ArmatoUChakravarthyBChiariniAChioffiFDal PraIWhitfieldJ. Leptin, sonic hedgehogs, and neurogenesis – a primary cilium’s taleon. J Alzheimers Dis (2012) 2:1000e1105.10.4172/2161-0460.1000e105
84
JacksonVMBreenDMFortinJPLiouAKuzmiskiJBLoomisAKet alLatest approaches for the treatment of obesity. Expert Opin Drug Discov (2015) 10:825–39.10.1517/17460441.2015.1044966
85
MeekTHMortonGJ. The role of leptin in diabetes: metabolic effects. Diabetologia (2016) 59:928–32.10.1007/s00125-016-3898-3
86
SternJHRutkowskiJMSchererPE. Adiponectin, leptin, and fatty acids in the maintenance of metabolic homeostasis through adipose tissue crosstalk. Cell Metab (2016) 23:770–84.10.1016/j.cmet.2016.04.011
87
ThonMHosoiTOzawaK. Possible integrative actions of leptin and insulin signaling in the hypothalamus targeting energy homeostasis. Front Endocrinol (2016) 7:138.10.3389/fendo.2016.00138
88
LevinBE. Metabolic imprinting: critical impact of the perinatal environment on the regulation of energy homeostasis. Philos Trans R Soc Lond B Biol Sci (2006) 361:1107–21.10.1098/rstb.2006.1851
89
PlagemannA. Perinatal nutrition and hormone-dependent programming of food intake. Horm Res (2006) 65:83–9.10.1159/000091511
90
BouretSG. Leptin, nutrition, and the programming of hypothalamic feeding circuits. In: LucasAMakridesMZieglerEE, editors. Importance of Growth for Health and Development. Basel: S. Karger AG (2010). p. 25–39.
91
LeeDABlackshawS. Feed your head: neurodevelopmental control of feeding and metabolism. Annual Review of Physiology (2014) 76:197–223.10.1146/annurev-physiol-021113-170347
92
RossMGDesaiM. Developmental programming of appetite/satiety. Ann Nutr Metab (2014) 64 Suppl 1:36–44.10.1159/000360508
93
SullivanELGroveKL. Metabolic imprinting in obesity. In: LanghansWGearyN, editors. Frontiers in Eating and Weight Regulation. Basel: S. Karger AG (2010). p. 186–94.
94
LauCRogersJMDesaiMRossMG. Fetal programming of adult disease implications for prenatal care. Obstet Gynecol (2011) 117:978–85.10.1097/AOG.0b013e318212140e
95
BouyerKSimerlyRB. Neonatal leptin exposure specifies innervation of presympathetic hypothalamic neurons and improves the metabolic status of leptin-deficient mice. J Neurosci (2013) 33:840–51.10.1523/JNEUROSCI.3215-12.2013
96
DjianeJAttigL. Role of leptin during perinatal metabolic programming and obesity. J Physiol Pharmacol (2008) 59:55–63.
97
GranadoMGarcia-CaceresCFuente-MartinEDiazFMelaVViverosMPet alEffects of acute changes in neonatal leptin levels on food intake and long-term metabolic profiles in rats. Endocrinology (2011) 152:4116–26.10.1210/en.2011-1233
98
MelaVDiazFLopez-RodriguezABVazquezMJGertlerAArgenteJet alBlockage of the neonatal leptin surge affects the gene expression of growth factors, glial proteins, and neuropeptides involved in the control of metabolism and reproduction in peripubertal male and female rats. Endocrinology (2015) 156:2571–81.10.1210/en.2014-1981
99
WalkerCDLongHWilliamsSRichardD. Long-lasting effects of elevated neonatal leptin on rat hippocampal function, synaptic proteins and NMDA receptor subunits. J Neurosci Res (2007) 85:816–28.10.1002/jnr.21173
100
YuraSItohHSagawaNYamamotoHMasuzakiHNakaoKet alRole of premature leptin surge in obesity resulting from intrauterine undernutrition. Cell Metab (2005) 1:371–8.10.1016/j.cmet.2005.05.005
101
AttigLSolomonGFerezouJAbdennebi-NajarLTaouisMGertlerAet alEarly postnatal leptin blockage leads to a long-term leptin resistance and susceptibility to diet-induced obesity in rats. Int J Obes (2008) 32:1153–60.10.1038/ijo.2008.39
102
BouretSG. Early life origins of obesity: role of hypothalamic programming. J Pediatr Gastroenterol Nutr (2009) 48:S31–8.10.1097/MPG.0b013e3181977375
103
VickersMHBreierBHCutfieldWSHofmanPLGluckmanPD. Fetal origins of hyperphagia, obesity, and hypertension and postnatal amplification by hypercaloric nutrition. Am J Physiol Endocrinol Metab (2000) 279:E83–7.
104
BouretSG. Organizational actions of metabolic hormones. Front Neuroendocrinol (2013) 34:18–26.10.1016/j.yfrne.2013.01.001
105
CaronESachotCPrevotVBouretSG. Distribution of leptin-sensitive cells in the postnatal and adult mouse brain. J Comp Neurol (2010) 518:459–76.10.1002/cne.22219
Summary
Keywords
leptin, neurogenesis, Xenopus, metamorphosis, Wnt/β-catenin
Citation
Bender MC, Sifuentes CJ and Denver RJ (2017) Leptin Induces Mitosis and Activates the Canonical Wnt/β-Catenin Signaling Pathway in Neurogenic Regions of Xenopus Tadpole Brain. Front. Endocrinol. 8:99. doi: 10.3389/fendo.2017.00099
Received
01 March 2017
Accepted
20 April 2017
Published
08 May 2017
Volume
8 - 2017
Edited by
Maximilian Michel, University of Michigan, USA
Reviewed by
Suraj Unniappan, University of Saskatchewan, Canada; Vance Trudeau, University of Ottawa, Canada
Updates
Copyright
© 2017 Bender, Sifuentes and Denver.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Robert J. Denver, rdenver@umich.edu
Specialty section: This article was submitted to Experimental Endocrinology, a section of the journal Frontiers in Endocrinology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.